IL6Myc mouse is an immunocompetent model for the development of aggressive multiple myeloma

Multiple Myeloma (MM) is a plasma cell neoplasm originating in the bone marrow and is the second most common blood cancer in the United States. One challenge in understanding the pathogenesis of MM and improving treatment is a lack of immunocompetent mouse models. We previously developed the IL6Myc...

Descripción completa

Detalles Bibliográficos
Autores principales: Pisano, Michael D., Sun, Fumou, Cheng, Yan, Parashar, Deepak, Zhou, Vivian, Jing, Xuefang, Sompallae, Ramakrishna, Abrudan, Jenica, Zimmermann, Michael T., Mathison, Angela, Janz, Siegfried, Pufall, Miles A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2023
Materias:
Article - Plasma Cell Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690922/
https://www.ncbi.nlm.nih.gov/pubmed/37439384
http://dx.doi.org/10.3324/haematol.2022.282538

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690922/
https://www.ncbi.nlm.nih.gov/pubmed/37439384
http://dx.doi.org/10.3324/haematol.2022.282538

Ejemplares similares